| |
| |
|
| Insider
Information: |
Hadas Nicole R. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
651,243 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$696,830 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
651,243 |
|
|
| Total
Value |
$696,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -269.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
|
2024-05-13 |
651,243 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2024-05-13 |
4 |
AS |
$1.26 |
$15,140 |
D/D |
(12,016) |
651,243 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2024-02-29 |
4 |
S |
$1.58 |
$9,439 |
D/D |
(5,974) |
663,259 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2024-02-27 |
4 |
AS |
$1.52 |
$11,265 |
D/D |
(7,411) |
669,233 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
149,300 |
676,644 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2023-05-25 |
4 |
S |
$1.22 |
$77,270 |
D/D |
(63,186) |
524,344 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
587,530 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
387,530 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2023-03-01 |
4 |
S |
$0.88 |
$11,437 |
D/D |
(13,034) |
287,530 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2023-02-27 |
4 |
S |
$0.81 |
$5,430 |
D/D |
(6,677) |
300,564 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2022-03-01 |
4 |
S |
$2.17 |
$31,490 |
D/D |
(14,507) |
304,241 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2022-02-28 |
4 |
S |
$2.15 |
$14,125 |
D/D |
(6,555) |
265,748 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
315,748 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2021-04-01 |
4 |
S |
$3.40 |
$3,604 |
D/D |
(1,060) |
272,303 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,192 |
273,363 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2021-03-01 |
4 |
S |
$3.40 |
$48,513 |
D/D |
(14,285) |
263,171 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
62,000 |
277,456 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2020-02-28 |
4 |
S |
$8.70 |
$61,335 |
D/D |
(7,050) |
212,756 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, Chief Legal Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
62,000 |
219,806 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CLO & Secretary |
• – – |
2019-04-11 |
4 |
D |
$7.70 |
$91,853 |
D/D |
(11,929) |
154,806 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CLO & Secretary |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
166,735 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, General Counsel, Sec. |
• – – |
2018-12-12 |
4 |
D |
$8.94 |
$180,365 |
D/D |
(20,175) |
101,284 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, General Counsel, Sec. |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
120,078 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, General Counsel, Sec. |
• – – |
2017-10-02 |
4 |
AS |
$19.64 |
$155,188 |
D/D |
(7,803) |
101,804 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, General Counsel, Sec. |
• – – |
2017-07-03 |
4 |
S |
$14.26 |
$22,156 |
D/D |
(1,554) |
109,607 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, General Counsel, Sec. |
• – – |
2017-04-03 |
4 |
S |
$9.18 |
$14,280 |
D/D |
(1,556) |
109,856 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
